Evidence map›Paper›PMID 33408205›Full record

ArticleBMJ open2021

Excess mortality in adults with documented diabetes in Germany: routine data analysis of all insurance claims in Germany 2013-2014.

Christian Schmidt, Lukas Reitzle, Christin Heidemann, Rebecca Paprott, Thomas Ziese, Christa Scheidt-Nave, Jens Baumert

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. [Development and Internal Validation of Case Definitions for Prevalence Estimation of Microvascular Complications of Diabetes in Routine Data].Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Christian SchmidtDepartment of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany schmidtchri@rki.de.ORCID 0000-0002-8419-8856
Lukas ReitzleDepartment of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
Christin HeidemannDepartment of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.ORCID 0000-0002-9413-2148
Rebecca PaprottDepartment of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.ORCID 0000-0003-2919-450X
Thomas ZieseDepartment of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
Christa Scheidt-NaveDepartment of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
Jens BaumertDepartment of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.ORCID 0000-0003-1399-6874
Robert Koch Institute · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesLittle is known about the age-specific excess mortality pattern of people with diagnosed diabetes in Germany. Thus, our goal was to determine the excess mortality in diagnosed diabetes overall and stratified by age and sex based on claims data.

designRoutine data analysis using a claims dataset from all statutory health-insured persons in Germany in 2013, which accounts for about 90% of the population.

participantsWe included persons who lived in Germany, were insured at least 360 days, were not self-paying any health services and were aged 30 years or older leading to a total number of 47.3 million insured persons for analyses. EXPOSURE: Diabetes was determined by the International Classification of Diseases-10 codes E10-E14, which were documented in 2013 in at least two-quarters on an outpatient setting or at least once on an inpatient setting. OUTCOME MEASURES: The vital status in the study population was drawn from the claims dataset for the year 2014. We derived the excess mortality estimated as an age-adjusted mortality rate ratio (MRR) by sex and for age groups using a Poisson model. MAIN

resultsWe found age-adjusted MRRs (95% CI) for diabetes of 1.52 (1.51 to 1.52) for women and 1.56 (1.56 to 1.56) for men. These figures declined with increasing age and were highest for ages 30-34 years with 6.76 (4.99 to 9.15) for women and 6.87 (5.46 to 8.64) for men, and lowest for age 95 years and older with 1.13 (1.10 to 1.15) for women and 1.11 (1.05 to 1.17) for men.

conclusionsWe derived deeply age-stratified figures on excess mortality in diabetes for Germany. Establishing a sustainable analysis of excess mortality is aimed at within the framework of diabetes surveillance.

Indexed as

Data AnalysisDiabetes MellitusAdultAged, 80 and overFemaleGermanyHumansInsurance, HealthMalePrevalenceepidemiologygeneral diabetespublic health

Identifiers

PMID33408205
PMCPMC7789443
OpenAlexW3120618482

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.